Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Unacylated ghrelin as therapeutic agent in the treatment of metabolic disorders

Unacylated ghrelin as therapeutic agent in the treatment of metabolic disorders

US Patent 8222217 · Granted Jul 17, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Modulation of ghrelin levels and ghrelin/unacylated ghrelin ratio using unacylat2017
Unacylated ghrelin and analogs as therapeutic agents for vascular remodeling in 2013
Unacylated ghrelin fragments as therapeutic agent in the treatment of obesity2012
Methods for promoting growth and survival of insulin-secreting cells2011
Methods for promoting growth and survival of insulin-secreting cells2011
Use of ghrelin and unacylated ghrelin compositions for treating insulin resistan2010
Use of ghrelin and unacylated ghrelin compositions for treating insulin resistan2010
Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses2010
Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses2009
Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses2009
Treatment of tumors by administration of growth hormone releasing compounds and 2000
Pharmaceutical composition for intranasal administration, comprising GH-releasin1991